Skin Therapy Letter HOME
Written for dermatologists by dermatologists. Indexed by the US National Library of Medicine.
Skin Information
NETWORK
Skin Therapy Letter About STL Subscribe Today SkinCareGuide Network Site Map
CUSTOM DERMATOLOGY SEARCH:
Loading

Update on Drugs and Drug News - Number 1 1996


Class Name/Company Approval Dates and Comments

Antifungal

Amphotericin B Lipid Complex Injection
Abelcet®
Liposomes

Approved by the FDA for the treatment of any progressive form of fungal infection that fails to respond to conventional treatment. This is in addition to its indication for aspergillosis.

Butenafine HCl Cream 1%
Mentax®
Schering/Penederm

Approved by the FDA on October 18, 1996 for the topical treatment of interdigital tinea pedis (athleteís foot).

Itraconazole
Sporanox®
Janssen (Johnson & Johnson)

Approved by the FDA on December 6, 1996 for the “pulse treatment” of onychomycosis of the fingernails. Available in 100 mg capsules. The dose is 200 mg twice daily for the first week of each month for two months. (The dose of 200 mg daily given for 12 weeks for onychomycosis of the toenails is already established.)

Antipsoriatic

Acitretin
Soriatane®
Roche

Approved by the FDA on October 28, 1996 for the treatment of severe recalcitrant psoriasis. Soriatane® will be available in 10 and 25 mg tablets.

Antiviral

Penciclovir cream 1%
Denavir®
SmithKline Beecham

Approved by the FDA for the treatment of recurrent herpes labialis. This is the first topical antiviral cleared for this indication in the USA.

Valacyclovir
Valtrex®
Glaxo-Wellcome

The FDA has approved valacyclovir for the new indication of treating first episode genital herpes. This indication is also approved by the Canadian HPB.

Hair transplantation

Laser device
Sharplan Silktouch laser®
Laser Industries

Received marketing approval from the FDA early this month. It is claimed to be the first such technology to be approved by the FDA for use in installing hair plugs.

Head lice prophylaxis

Permethrin lotion
Nix®
Warner-Lambert

Permethrin was recently approved by the FDA for prophylactic use during head lice epidemics. OTC.

Parasitic infections

Ivermectin
Mectizan® (6 mg tablet)
Merck

Approved by the FDA on November 22, 1996 for the treament of strongyloidiasis and onchocerciasis.
*Undergoing clinical trial for human scabies.


In this issue:

  1. Erythromycin 3% & Benzoyl peroxide 5% Gel for Acne
  2. Scalp Psoriasis
  3. Female Hair Loss
  4. Update on Drugs and Drug News - Number 1 1996